help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Endocrinology, doi:10.1210/en.2007-0459
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
148/9/4226    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McCall, K. D.
Right arrow Articles by Kohn, L. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McCall, K. D.
Right arrow Articles by Kohn, L. D.
Endocrinology Vol. 148, No. 9 4226-4237
Copyright © 2007 by The Endocrine Society

High Basal Levels of Functional Toll-Like Receptor 3 (TLR3) and Noncanonical Wnt5a Are Expressed in Papillary Thyroid Cancer and Are Coordinately Decreased by Phenylmethimazole Together with Cell Proliferation and Migration

Kelly D. McCall, Norikazu Harii, Christopher J. Lewis, Ramiro Malgor, Won Bae Kim, Motoyasu Saji, Aimee D. Kohn, Randall T. Moon and Leonard D. Kohn

Edison Biotechnology Institute and College of Osteopathic Medicine (K.D.M., N.H., C.J.L., R.M., W.B.K., L.D.K.), Ohio University, Athens, Ohio 45701; The Ohio State University, Arthur G. James Cancer Center and Richard J. Solove Research Institute (M.S.), Columbus, Ohio 43210; The Howard Hughes Medical Institute (A.D.K., R.T.M.) and Department of Hematology (A.D.K.), University of Washington, Seattle, Washington 98195; and Department of Internal Medicine (W.B.K.), Asan Medical Center, University of Ulsan College of Medicine, Seoul 138-736, Korea

Address all correspondence and requests for reprints to: Leonard D. Kohn, Konneker Research Building, Room 077, The Ridges, Building 25, Ohio University, Athens, Ohio 45701. E-mail: kohnl{at}ohiou.edu.

High basal levels of TLR3 and Wnt5a RNA are present in papillary thyroid carcinoma (PTC) cell lines consistent with their overexpression and colocalization in PTC cells in vivo. This is not the case in thyrocytes from normal tissue and in follicular carcinoma (FC) or anaplastic carcinoma (AC) cells or tissues. The basally expressed TLR3 are functional in PTC cells as evidenced by the ability of double-strand RNA (polyinosine-polycytidylic acid) to significantly increase the activity of transfected NF-{kappa}B and IFN-ß luciferase reporter genes and the levels of two end products of TLR3 signaling, IFN-ß and CXCL10. Phenylmethimazole (C10), a drug that decreases TLR3 expression and signaling in FRTL-5 thyrocytes, decreases TLR3 levels and signaling in PTC cells in a concentration-dependent manner. C10 also decreased Wnt5a RNA levels coordinate with decreases in TLR3. E-cadherin RNA levels, whose suppression may be associated with high Wnt5a, increased with C10 treatment. C10 simultaneously decreased PTC proliferation and cell migration but had no effect on the growth and migration of FC, AC, or FRTL-5 cells. C10 decreases high basal phosphorylation of Tyr705 and Ser727 on Stat3 in PTC cells and inhibits IL-6-induced Stat3 phosphorylation. IL-6-induced Stat3 phosphorylation is important both in up-regulating Wnt5a levels and in cell growth. In sum, high Wnt5a levels in PTC cells may be related to high TLR3 levels and signaling; and the ability of phenylmethimazole (C10) to decrease growth and migration of PTC cells may be related to its suppressive effect on TLR3 and Wnt5a signaling, particularly Stat3 activation.




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. A. Christman II, D. J. Goetz, E. Dickerson, K. D. McCall, C. J. Lewis, F. Benencia, M. J. Silver, L. D. Kohn, and R. Malgor
Wnt5a is expressed in murine and human atherosclerotic lesions
Am J Physiol Heart Circ Physiol, June 1, 2008; 294(6): H2864 - H2870.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
K. Jazdzewski, E. L. Murray, K. Franssila, B. Jarzab, D. R. Schoenberg, and A. de la Chapelle
Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma
PNAS, May 20, 2008; 105(20): 7269 - 7274.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society